CXCR4
(old designation: LESTR , HUMSTR). has been identified
also asNPYRL (neuropeptide Y receptor-like) and HM89 .
CXCR4 also known as fusin acts as one of the receptors
for CXC-Chemokines . Two variants of the receptor, designated
CXCR4A and CXCR4B , have been described. Expression of
CXCR3 and CXCR4 on human NK-cells is up-regulated by TGF-beta-1
, but not by IFN-gamma , MIP-3-beta , MDC , TARC or I-309.
The new designation for this receptor is CD184. CXCR4 has
been shown to be a cofactor required for entry of HIV into
cells expressing CD4 . It functions as an inhibitor of
infection by T-cell-tropic HIV-1 strains. During the early
stages of HIV infection, viral isolates tend to use the
chemokine receptor CCR5 for viral entry, while later isolates
tend to use CXCR4. Both splice variants of CXCR4 have been
shown to function as receptors for SDF-1 . In cell lines
expressing CXCR4 and CD4 , and in blood lymphocytes, SDF-1
is a powerful inhibitor of infection by lymphocyte-tropic
HIV-1 strains.
Human CXCR4 exists in antigenically distinct conformations
on many cell lines and primary cell types. As a result, to
efficiently detect cell surface CXCR4, an antibody that recognizes
multiple CXCR4 conformations is desirable. The customer should
consult the publication by Baribaud, et al., 2001 J. Virol.
75:8957 as a guide for the optimal selection of monoclonals.
Monoclonal 44716 has been shown to recognize multiple CXCR4
conformations. Use of other monoclonals may result in an
underestimation of the density of CXCR4 expression on certain
cell types. The above reference also contains epitope mapping
details for many CXCR4 monoclonals.
|